
Pharma Innovation Tech Congress 2021 - AI, IoT, Blockchain, Big Data & Digitalisation for Pharma
- 9.30 am - 5 pm
- 26 August 2021 - 26 August 2021
- Virtual Conference (Time Zone - IST)
Virtue Insight is delighted to announce its Pharma Innovation Tech Congress 2021 to be held on 26th August 2021(Virtual Conference).
Technology has slowly been creeping to the core of the Pharma industry. Especially, in the last two decades, the pharma industry has shown a significant amount of growth. The market valuation of such companies is increasing exponentially after the COVID-19. According to market, the global pharmaceutical industry is expected to cross $1.57 trillion USD by 2023.
According to the recent report The "Artificial Intelligence of Things: AIoT Market by Technology and Solutions 2020 - 2025" from ResearchAndMarkets.com, the global AIoT market will reach $65.9 billion by 2025, growing at a compound annual growth rate (CAGR) of 39.1%. According to recent research, by 2020, 40% of IoT devices will be used in the healthcare industry, while today; the medical IoT has a 22% share of the whole IoT market. The world population is aging and needs innovative healthcare solutions. For example, according to market, the elderly population in Europe increased by 22% from 2000 to 2017, resulting in rising demand and higher prices in the health industry. In this scenario, IoT could be a key to unlocking personalized journeys for patients.
The global demand for the Internet of Things (IoT) in the healthcare market will reach $534.3 billion by 2025. This projected growth highlights the pivotal role IoT devices will continue to play as they are used for a wide variety of applications, such as patient monitoring, operations management and beyond. The global big data analytics in healthcare market size was valued at $16.87 billion in 2017 and is projected to reach $67.82 billion by 2025, growing at a CAGR of 19.1% from 2018 to 2025. The real-world evidence solutions market study presents historical market data in terms of value (2018 & 2019), estimated current data (2020), and forecasts for 2027 - by component, application, end user, and geography. The study also evaluates industry competitors and analyzes the market at a regional and country level.
Join our new break-out sessions to deep dive into industry-specific Pharma Innovation Tech and explore real use cases and lessons learned by our customers.
We look forward to seeing you all there!
KEY THEMES DISCUSSED: -
- Impact of Digitization in Pharma and involving patients in digital age
- Challenges and opportunities in digitalization
- Challenges, Opportunities and Implementation AI
- Resolving the tech issues in the industry
- RWD and RWE drive in Pharma
- Patient recruitment using AI for clinical trials & How can AI change the Pharma industry
- Find out the ways to secure Pharma from lack of data integration and access of data
- Drug discovery by AI
- How IoT data to be handled – are they secure?
- IoT made remote patient monitoring simpler?
- Addressing the future of AI & IoT in Pharma industry
- Blockchain and Big Data in Pharma industry 4.0
- Challenges like data inconsistency, privacy, transparency, security and traceability
- DO’s and DON’T’s on Blockchain and its growth in this new decade
- How Big data speeding up the drug discovery?
- Strategic planning and smart decision-making in Big Data
- Solutions for data integration and storage, data quality, security and privacy of data
- How Pharma will handle complexity of data in RWD?
- RWE helps to get custom-made treatments and drug therapies for patients
- Better understanding about data quality and data privacy
- What kind of changes needed to be place in RWE? Compelling with regulatory
WHO SHOULD ATTEND AND WHO YOU’LL MEET: -
CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors and Team Leaders from the following areas:
- Pharmaceuticals
- Biotech
- Artificial Intelligence
- Data Science
- Blockchain
- Machine Learning
- IoT
- Advanced Analytics
- Innovation
- Big Data
- Deep Learning
- BDM
- Business Operations
- Scientific Affairs
- Commercial Affairs
- Research & Development
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Speakers
Speakers
RASHMI HEGDE
Vice President Medical
Cipla
MANU GUPTA
Vice President – Information Technology
Cadila
MYLES FURNACE
Real World Evidence Director Global Medical Affairs,
Ipsen (UK)
NEHA GUPTA
Senior Digital Product Owner Strategy and Transformation
Ipsen (UK)
NEHA MISHRA
Associate Director, Service Delivery
Novartis
ANKEET BHAT
Chief Strategy Officer
MapmyIndia
VARUN CHUGH
Director Technology Transformation
Novartis
Director, Real World Investigator
Sanofi
NAGENDRA KRISHNA SINGH
Associate Director - PD & Tech Transfer
Dr. Reddy’s Laboratories
HRISHIKESH NASHIKKAR
Associate Director Blockchain
Novartis
Director
Futures.health (UK)
Business Information Security Expert
Novartis
PRATHAMESH KARMALKAR
Principal Data Scientist - Text Analytics
Merck KGaA
Chief Information Security Officer
Alkem Laboratories
Corporate CIO
Piramal
Country Head - Data Privacy (India, South Asia Sub-Saharan Africa)
Novartis
Head- Digital Innovation & Strategic Initiatives
Abbott
ASHUTOSH MITTAL
Head – Global Quality Digital & Program Leader – Digital Transformation
Biocon
Business Unit Head -Parenteral Nutrition
Fresenius Kabi
Head of Cyber Security & Data Privacy
GAVS Technologies
Global IoT Healthcare Lead
Vodafone (UK)
Life Sciences Business Consulting Executive
EPAM Systems (US)
Founder
Incubate.bio (UK)
Founder
Beyond Identity (UK)
Co-Founder
EasyCups
Regional Senior Manager - Market Access
Johnson & Johnson
Senior General Manager Strategy
Lupin
Asia Digital Client Partner
Pfizer
Program Lead - Digital Transformation
Dr. Reddy’s Laboratories
Schedule
09:30 - Welcome Address & Virtual Conference Platform Instructions
TEXT ANALYTICS AND INDUSTRY 4.0
09:40 – Improving Consumer Experience for Medical Information using Text Analytics
- A strong business need to efficiently consolidate customer feedback from HCP, Patients, etc.
- Unstructured data in form of medical / customer inquiry data
- Significant time and effort is spent in manually tagging / classifying data
- Leveraging Advanced & Text Analytics to better equip medical information teams
PRATHAMESH KARMALKAR, Principal Data Scientist - Text Analytics, Merck KGaA
10:10 – Industry 4.0 application in Pharma Manufactucturing arena
ADITYA KHADILKAR, Program Lead - Digital Transformation, Dr. Reddy's Laboratories
10:40 – Morning Coffee/Tea & Discussion
CHALLENGES & OPPORTUNITIES
11:00 – DISCUSSION WITH EXPERTS: AI & IoT – Challenges, Opportunities and Implementation
- How is AI resolving the tech problems faced by the industry? How will the near future be?
- How is AI being put to utilize in the battle against the epidemic?
- Application of AI to clinical trial and Real-World Data - Blurring the boundaries
- How can AI change the Pharma industry?
- Challenges in AI, especially a lack of data integration and access of data?
- Major threats and challenges of drug discovery by AI
- Huge data delivered by IoT devices, how are they to be handled – data secured?
- Remote Patient monitoring via IoT made simpler
- What’s instore for us with this AI & IoT for this era?
Moderator:
VINAY WANDREKAR, Business Information Security Expert, Novartis
Panellists:
MANU GUPTA, Vice President – Information Technology, Cadila
BIJENDER KUMAR MISHRA, Chief Information Security Officer, Alkem Laboratories
DHAVAL PANDYA, Corporate CIO, Piramal
VAIBHAV RAO, Asia Digital Client Partner, Pfizer
JON LEE-DAVEY, Global IoT Healthcare Lead, Vodafone (UK)
RAMINDERPAL SINGH, Founder, Incubate.bio (UK)
ASHUTOSH INAMDAR, Senior General Manager Strategy, Lupin
12:10 – Patient recruitment using AI for clinical trials & How can AI change the Pharma industry
- How AI can improve clinical trials
- How does future looks like
- How AI is changing the Pharma industry
VARUN CHUGH, Director Technology Transformation, Novartis
12:40 - Networking luncheon
SMART LABS & LABORATORY
13:30 – We have reached a tipping point in drug discovery. Start planning for fewer labs and more computers!
- Computational biology is producing insights comparable or sometimes better than wet lab approaches.
- This includes structural modelling, quasi-mechanistic modelling, predictive (AI/ML) algorithms, and even causal inferences.
- Several large Pharma companies and start-ups have responded and are significantly investing in modeling-first approaches.
- However, in the next 2-3 years modelling-first approaches will become a critical requirement of the workflow, for scientists to remain competitive.
- This talk discusses the above points from both technology and industry perspectives, and proposes that the adoption chasm has already been crossed.
RAMINDERPAL SINGH, Founder, Incubate.bio (UK)
BLOCKCHAIN AND BIG DATA
14:00 – DISCUSSION WITH EXPERTS: Blockchain and Big Data in Pharma industry 4.0
- Challenges like data inconsistency, increasing customer expectation towards privacy, transparency, security and traceability?
- Implementation DO’s and DON’T’s on Blockchain products?
- How Blockchain helps to decrease the number of Pharma frauds?
- Blockchain growth in the next 5 years?
- How Big data speeding up the drug discovery?
- In what way Big data give hands in strategic planning and smart decision-making?
- What are preferable solutions for data integration and storage, data quality, security and privacy of data?
Moderator:
SIDDHI TRIVEDI, Founder, Beyond Identity (UK)
Panellists:
RASHMI HEGDE, Vice President Medical, Cipla
HRISHIKESH NASHIKKAR, Associate Director Blockchain, Novartis
KISHAN BARCHHA, Co-Founder, EasyCups
14:50 – Afternoon Tea/Coffee
DIGITALIZATION, RWE AND RWD
15:10 - DISCUSSION WITH EXPERTS: Significance of Digitalization in Pharma
- How is digital transformation impacting the Pharma Industries?
- How can your company prepare for this digital transformation wave?
- Challenges and opportunities in moving to digitalization?
- How patients are involved in digital age in Pharma industry? Is their information secured? What is to be done?
- Customized services by smart innovation like apps, smart watch etc.....
- Commercial model evolution using digital in branded generics markets
- Zero Trust with Layered Defense
Moderator:
SANJAY GOHIL, Director, Futures.health (UK)
Panellists:
NEHA MISHRA, Associate Director, Service Delivery, Novartis
NAGENDRA KRISHNA SINGH, Associate Director - PD & Tech Transfer, Dr. Reddy's Laboratories
ANKEET BHAT, Chief Strategy Officer, MapmyIndia
NEHA GUPTA, Senior Digital Product Owner Strategy and Transformation, Ipsen (UK)
DEBASHISH ROY, Head- Digital Innovation & Strategic Initiatives, Abbott
ASHUTOSH MITTAL, Head – Global Quality Digital & Program Leader – Digital Transformation, Biocon
JEFF KIM, Life Sciences Business Consulting Executive, EPAM Systems (US)
16:10 – DISCUSSION WITH EXPERTS: RWD and RWE drive in Pharma
- How Pharma will handle complexity of data in RWD?
- Discussing how the RWE helps to get custom-made treatments and drug therapies for patients
- What helps us to have a better understanding about data quality and data privacy?
- RWE gives efficient and cost-effective clinical trials? How?
- What are complications will rise by inserting new data source? And it leads to breakup in data?
- Obtaining patient-centric using RWE
- What kind of changes needed to be place in RWE?
- Compelling with regulatory
- Market access for innovative medicines in emerging markets
Moderator:
VISHVAJIT M KARANDIKAR, Business Unit Head -Parenteral Nutrition, Fresenius Kabi
Panellists:
MYLES FURNACE, Real World Evidence Director, Global Medical Affairs, Ipsen (UK)
KAVITHA SRINIVASULU, Head of Cyber Security & Data Privacy, GAVS Technologies
KAVITA LAMROR, Director, Real World Investigator, Sanofi
LALIT RAUTE, Regional Senior Manager - Market Access, Johnson & Johnson
NITIN DHAVATE, Country Head - Data Privacy (India, South Asia, Sub-Saharan Africa), Novartis
17:00 - End of conference